Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court ...

The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the ...

After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of opi ...

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic ...

Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...

Purdue Pharma, the pharmaceutical company responsible for OxyContin, has recently filed a new bankruptcy plan outlining a ...

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion of cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.

Utah has more than half a billion dollars in opioid settlement funds to allocate over the next 15 years, aiming to combat addiction effectively.

The Supreme Court last year blocked a previous settlement proposal from Purdue, arguing that the plan would afford the ...